Breaking News
COVID-19 Vaccinations Produced Significant Revenues
March 1, 2022 • 9:14 am CST
During the C)VID-19 pandemic, the launch of innovative vaccines against COVID-19 proved financially rewarding. The pharma companies - Moderna, Pfizer/BioNTech, and Johnson & Johnson/Janssen - recently announced combined revenues of about $31 billion in 2021.
During early 2022, these company's Wall Street reports also indicate solid orders for the rest of the year.
In the U.S., about 65% of the population is 'fully-vaccinated,' which indicates plenty of future COVID-19 vaccinations is possible in 2022.